테이코신주(테이코플라닌)
Recall Summary Taiko Injection (Teicoplanin) is being recalled in South Korea because test results showed it exceeded moisture limits during post-market stability testing. The recall affects three product batches with specific barcodes and is classified as a Class II recall. The product is manufactured by Ildong Pharmaceuticals.
- Recalling firm
- 일동제약(주)
- Product
- 테이코신주(테이코플라닌) (Barcode: 8806429022706, 8806429022713, 8806429022720)
- Reason
- 시판후안정성시험에서부적합(수분시험기준초과)에따른영업자회수
- Classification
- Class II
- Category
- drug recall
- Country
- South Korea
- Agency
- MFDS-DRUG
- Recall date
- 2026-06-05
- Status
- Ongoing
- Distribution
- South Korea
Official recall notice from MFDS-DRUG
Recall details on Nibble Recalls: https://trynibble.app/recalls/61ee4064-4c68-4b95-ac05-76fa24b232c6